-
1
-
-
0346165752
-
Origins of receptor theory'
-
See J Parascandola, Origins of receptor theory', Trends Pharmacol. Sci., 1980, 1: 189-92;
-
(1980)
Trends Pharmacol. Sci.
, vol.1
, pp. 189-192
-
-
Parascandola, J.1
-
2
-
-
0242294281
-
The development of receptor theory
-
idem, M J Parnham and J Bruinvels (eds), Amsterdam, Elsevier
-
idem, 'The development of receptor theory', in M J Parnham and J Bruinvels (eds), Discoveries in pharmacology, vol. 3, Pharmacological methods, receptors and chemotherapy, Amsterdam, Elsevier, 1986, pp. 129-56.
-
(1986)
Discoveries in Pharmacology, Vol. 3, Pharmacological Methods, Receptors and Chemotherapy
, pp. 129-156
-
-
-
3
-
-
0141782130
-
Part of a scientific master plan? Paul Ehrlich and the origins of his receptor concept
-
On the development of the receptor concept by Paul Ehrlich, see C-R Prüll, 'Part of a scientific master plan? Paul Ehrlich and the origins of his receptor concept', Med. Hist., 2003, 47: 332-56;
-
(2003)
Med. Hist.
, vol.47
, pp. 332-356
-
-
Prüll, C.-R.1
-
4
-
-
2142832180
-
"Receptive substances": John Newport Langley (1852-1925) and his path to a receptor theory of drug action
-
on John Langley's role in the elaboration of receptor theory, see A-H Maehle, '"Receptive substances": John Newport Langley (1852-1925) and his path to a receptor theory of drug action', Med. Hist., 2004, 48: 153-74.
-
(2004)
Med. Hist.
, vol.48
, pp. 153-174
-
-
Maehle, A.-H.1
-
5
-
-
0036688216
-
The emergence of the drug receptor theory
-
Aug. on p. 641
-
A-H Maehle, C-R Prüll and R F Halliwell, 'The emergence of the drug receptor theory'. Nature Reviews, Aug. 2002, 1: 637-41, on p. 641.
-
(2002)
Nature Reviews
, vol.1
, pp. 637-641
-
-
Maehle, A.-H.1
Prüll, C.-R.2
Halliwell, R.F.3
-
6
-
-
0037264395
-
Drugs and cells-pioneering the concept of receptors
-
See also C-R Prüll, A-H Maehle, and R F Halliwell, 'Drugs and cells-pioneering the concept of receptors', Pharmacy in History; 2003, 45: 18-30.
-
(2003)
Pharmacy in History
, vol.45
, pp. 18-30
-
-
Prüll, C.-R.1
Maehle, A.-H.2
Halliwell, R.F.3
-
7
-
-
85039250484
-
-
note 2 above
-
See the time line in Maehle, et al., Pharmacy in History; op. cit., note 2 above, p. 638.
-
Pharmacy in History
, pp. 638
-
-
Maehle1
-
8
-
-
0024151101
-
The "pharmacological toolmaker's" rational approach to drug design: An appreciation of Sir James Black
-
On Black, see V P Gerskowitch, R A D Hull, and N P Shankley, 'The "pharmacological toolmaker's" rational approach to drug design: an appreciation of Sir James Black', Trends Pharmacol. Sci., 1988, 9: 435-7.
-
(1988)
Trends Pharmacol. Sci.
, vol.9
, pp. 435-437
-
-
Gerskowitch, V.P.1
Hull, R.A.D.2
Shankley, N.P.3
-
9
-
-
85039243975
-
Black, James Whyte
-
20 vols, London, Nature Publications Group
-
See also V Quirke, 'Black, James Whyte', Encyclopedia of life sciences, 20 vols, London, Nature Publications Group, 2002, vol. 3, pp. 300-1.
-
(2002)
Encyclopedia of Life Sciences
, vol.3
, pp. 300-301
-
-
Quirke, V.1
-
10
-
-
0017073993
-
Ahlquist and the development of beta-adrenoceptor antagonists
-
J W Black, 'Ahlquist and the development of beta-adrenoceptor antagonists', Postgrad, med. J., 1976, 52, Suppl. 4:
-
(1976)
Postgrad, Med. J.
, vol.52
, Issue.SUPPL. 4
-
-
Black, J.W.1
-
11
-
-
85039243662
-
-
B I Hoffbrand, R G Shanks, and I Brick (eds), Amsterdam, 26-28 Sept. on p. 11
-
B I Hoffbrand, R G Shanks, and I Brick (eds), Ten years of propranolol: a symposium on the history and future of beta-blockade, (Amsterdam, 26-28 Sept. 1975): 11-13, on p. 11.
-
(1975)
Ten Years of Propranolol: A Symposium on the History and Future of Beta-blockade
, pp. 11-13
-
-
-
13
-
-
55049133944
-
From evidence to market: Alfred Spinks' 1953 survey of new fields for pharmacological research, and the origins of ICI's cardiovascular programme
-
V Berridge and K Loughlin (eds), London, Routledge
-
For a more detailed analysis of the origins of ICI's cardiovascular research programme, see V Quirke, 'From evidence to market: Alfred Spinks' 1953 survey of new fields for pharmacological research, and the origins of ICI's cardiovascular programme', in V Berridge and K Loughlin (eds), Medicine, the market, and the mass media: producing health in the twentieth century, London, Routledge, 2005, pp. 144-69.
-
(2005)
Medicine, the Market, and the Mass Media: Producing Health in the Twentieth Century
, pp. 144-169
-
-
Quirke, V.1
-
14
-
-
85039246767
-
-
2 vols, London, Oxford University Press, 13
-
W J Reader, Imperial Chemical Industries: a history, 2 vols, London, Oxford University Press, 1975, vol. 2, pp. 3, 13.
-
(1975)
Imperial Chemical Industries: A History
, vol.2
, pp. 3
-
-
Reader, W.J.1
-
15
-
-
0347349496
-
Chemistry and biomedicine in an industrial setting: The invention of the sulfa drugs
-
S H Mauskopf (ed.), Philadelphia, University of Pennsylvania Press
-
See J Lesch, 'Chemistry and biomedicine in an industrial setting: the invention of the sulfa drugs', in S H Mauskopf (ed.), Chemical sciences in the modern world, Philadelphia, University of Pennsylvania Press, 1993, pp. 158-215.
-
(1993)
Chemical Sciences in the Modern World
, pp. 158-215
-
-
Lesch, J.1
-
18
-
-
33845349163
-
IC Pharmaceutical
-
Sept.
-
K Holland, 'IC Pharmaceutical', Pharmaceutical Journal, Sept. 1987, 12: 286-8.
-
(1987)
Pharmaceutical Journal
, vol.12
, pp. 286-288
-
-
Holland, K.1
-
19
-
-
0025574832
-
Francis Leslie Rose, 1909-1988
-
on p. 498
-
See also C W Suckling and B W Langley, 'Francis Leslie Rose, 1909-1988', Bio. Mem. F.R.S., 1990, 36: 491-524, on p. 498.
-
(1990)
Bio. Mem. F.R.S.
, vol.36
, pp. 491-524
-
-
Suckling, C.W.1
Langley, B.W.2
-
20
-
-
85039244391
-
-
note 8 above
-
Reader, Bio. Mem. F.R.S., op. cit., note 8 above, vol. 2, p. 286.
-
Bio. Mem. F.R.S.
, vol.2
, pp. 286
-
-
Reader1
-
22
-
-
85039246496
-
-
note 6 above
-
Kennedy, Bio. Mem. F.R.S., op. cit., note 6 above, pp. 127-9.
-
Bio. Mem. F.R.S.
, pp. 127-129
-
-
Kennedy1
-
23
-
-
85039247004
-
-
note 12 above
-
Holland, Bio. Mem. F.R.S., op. cit., note 12 above, vol. 2, p. 286.
-
Bio. Mem. F.R.S.
, vol.2
, pp. 286
-
-
Holland1
-
24
-
-
85039250151
-
-
note 8 above
-
Reader, Bio. Mem. F.R.S., op. cit., note 8 above, vol. 2, p. 459;
-
Bio. Mem. F.R.S.
, vol.2
, pp. 459
-
-
Reader1
-
26
-
-
33845301954
-
-
PhD thesis, University of Aston, Birmingham
-
J A Woodbridge, 'Social aspects of pharmaceutical innovation: heart disease', PhD thesis, University of Aston, Birmingham, 1981, p. 26.
-
(1981)
Social Aspects of Pharmaceutical Innovation: Heart Disease'
, pp. 26
-
-
Woodbridge, J.A.1
-
29
-
-
85039252715
-
-
minutes of 1st meeting, 19 Jan.
-
CPR 3: minutes of 2nd meeting of the Chemotherapeutic Research Committee, Ibid., minutes of 1st meeting, 19 Jan. 1948. A member of the committee, Dr J Madinaveitia, for example, drew the Committee's attention to the "importance of biochemical work as a basis for new ideas and new lines of synthetic work". However, pharmacology rather than biochemistry was to provide ICI with their first angle of approach to the problem of hypertension.
-
(1948)
CPR 3: Minutes of 2nd Meeting of the Chemotherapeutic Research Committee
-
-
-
31
-
-
85039244222
-
-
Research Department, Biological Group (Diseases of Organic Dysfunction) Report, Oct.-Dec.
-
The term "diseases of organic dysfunction", rather than the now more familiar "chronic diseases", was used at ICI to distinguish their study from that of infectious diseases. ICI CPR 33: Research Department, Biological Group (Diseases of Organic Dysfunction) Report, Oct.-Dec. 1954.
-
(1954)
ICI CPR
, vol.33
-
-
-
32
-
-
85039246344
-
-
31 March
-
ICI CPR 3: 31 March 1953;
-
(1953)
ICI CPR
, vol.3
-
-
-
33
-
-
33845297591
-
-
1 Dec.
-
ICI CPR 8: 1 Dec. 1954;
-
(1954)
ICI CPR
, vol.8
-
-
-
34
-
-
33845344276
-
-
joint plan for
-
ICI CPR 11: joint plan for 1954.
-
(1954)
ICI CPR
, vol.11
-
-
-
35
-
-
33845318472
-
'Dr James Raventos', obituary
-
On Raventos, see D G Davey, 'Dr James Raventos', obituary, Br. J. Pharmacol., 1983, 80: 3.
-
(1983)
Br. J. Pharmacol.
, vol.80
, pp. 3
-
-
Davey, D.G.1
-
36
-
-
0021552813
-
Alfred Spinks, 1917-1982
-
A W Johnson, F L Rose and C W Suckling, 'Alfred Spinks, 1917-1982', Bio. Mem. F.R.S., 1984, 30: 567-94.
-
(1984)
Bio. Mem. F.R.S.
, vol.30
, pp. 567-594
-
-
Johnson, A.W.1
Rose, F.L.2
Suckling, C.W.3
-
37
-
-
33845286824
-
-
Research Report of the Biological Group (Pharmacological Section) for July-Dec.
-
ICI CPR 35: Research Report of the Biological Group (Pharmacological Section) for July-Dec. 1955.
-
(1955)
ICI CPR
, vol.35
-
-
-
38
-
-
0000908951
-
An experimental approach to the problem of disordered lipid metabolism
-
J M Thorp, 'An experimental approach to the problem of disordered lipid metabolism', J. Atheroscler. Res., 1963, 3: 351-60.
-
(1963)
J. Atheroscler. Res.
, vol.3
, pp. 351-360
-
-
Thorp, J.M.1
-
41
-
-
85039250056
-
-
Research Department Period Report, 22 Jan.
-
ICI CPR 50, 50/3: Research Department Period Report, 22 Jan. 1959.
-
(1959)
ICI CPR 50
, vol.50
, Issue.3
-
-
-
42
-
-
85039252938
-
-
note 1 above
-
Prüll, ICI CPR, op. cit., note 1 above;
-
ICI CPR
-
-
Prüll1
-
43
-
-
85039243442
-
-
note 1 above
-
also Maehle, ICI CPR, op. cit., note 1 above.
-
ICI CPR
-
-
Maehle1
-
44
-
-
85039243766
-
The development of receptor theory
-
note 1 above
-
Parascandola, 'The development of receptor theory', ICI CPR, op. cit., note 1 above, pp. 150-3;
-
ICI CPR
, pp. 150-153
-
-
Parascandola1
-
45
-
-
2142736894
-
A J Clark: Quantitative pharmacology and the receptor theory
-
idem
-
idem, 'A J Clark: quantitative pharmacology and the receptor theory'. Trends Pharmacol Sci., 1982, 3: 421-3.
-
(1982)
Trends Pharmacol Sci.
, vol.3
, pp. 421-423
-
-
-
46
-
-
85039244974
-
-
note 2 above
-
On Clark, see also Prüll, et al., Trends Pharmacol Sci., op. cit., note 2 above, pp. 26-7.
-
Trends Pharmacol Sci.
, pp. 26-27
-
-
Prüll1
-
47
-
-
0004144022
-
-
London, Methuen
-
For an indirect view of the development and gradual acceptance of receptor theory, see A Albert's series of textbooks on Selective toxicity. It is interesting to note that it was not until Albert became more confident in the scientific basis of receptor theory, in the 3rd edition of the series published in 1965, that he began to appreciate the role played by Clark. A Albert, Selective toxicity, 3rd ed., London, Methuen, 1965, pp. 45-7.
-
(1965)
Selective Toxicity, 3rd Ed.
, pp. 45-47
-
-
Albert, A.1
-
48
-
-
31444441453
-
Alfred Joseph Clark, 1885-1941
-
On Clark's life and scientific career, see E V Vemey and I Barcroft, 'Alfred Joseph Clark, 1885-1941', Obit. Not. F.R.S, 1939-41, 3: 969-84.
-
(1939)
Obit. Not. F.R.S
, vol.3
, pp. 969-984
-
-
Vemey, E.V.1
Barcroft, I.2
-
49
-
-
85039245414
-
The development of receptor theory
-
note 1 above
-
Parascandola, 'The development of receptor theory', Obit. Not. F.R.S, op. cit., note 1 above, pp. 149-50.
-
Obit. Not. F.R.S
, pp. 149-150
-
-
Parascandola1
-
50
-
-
28244452499
-
The antagonism of acetylcholine and of quaternary ammonium salts
-
A J Clark and J Raventos, 'The antagonism of acetylcholine and of quaternary ammonium salts', Q. J. Exp. Phys., 1937, 26: 375-92.
-
(1937)
Q. J. Exp. Phys.
, vol.26
, pp. 375-392
-
-
Clark, A.J.1
Raventos, J.2
-
52
-
-
85039254959
-
J Clark
-
note 31 above
-
Parascandola, 'J Clark', Q. J. Exp. Phys., op. cit., note 31 above, p. 422.
-
Q. J. Exp. Phys.
, pp. 422
-
-
Parascandola1
-
53
-
-
85039254057
-
-
note 2 above
-
Clark is quoted in Prüll, et al., Q. J. Exp. Phys., op. cit., note 2 above, p. 27.
-
Q. J. Exp. Phys.
, pp. 27
-
-
Prüll1
-
54
-
-
85039242649
-
The development of receptor theory
-
note 1 above
-
Parascandola, 'The development of receptor theory', Q. J. Exp. Phys., op. cit., note 1 above, p. 151;
-
Q. J. Exp. Phys.
, pp. 151
-
-
Parascandola1
-
55
-
-
85039254959
-
A J Clark
-
idem, note 31 above
-
idem, 'A J Clark', op. cit., note 31 above, p. 422.
-
Q. J. Exp. Phys.
, pp. 422
-
-
-
56
-
-
77049220618
-
Affinity and intrinsic activity in the theory of competitive inhibition
-
E J Ariëns, 'Affinity and intrinsic activity in the theory of competitive inhibition', Arch. Int. Pharma. Thé., 1954, 99: 32-49;
-
(1954)
Arch. Int. Pharma. Thé.
, vol.99
, pp. 32-49
-
-
Ariëns, E.J.1
-
60
-
-
0004144022
-
-
London, Methuen
-
See also A Albert, Selective toxicity, 5th ed., London, Methuen, 1973, p. 220.
-
(1973)
Selective Toxicity, 5th Ed.
, pp. 220
-
-
Albert, A.1
-
64
-
-
28244486354
-
On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari'
-
J N Langley, On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari', J. Physiol., 1905, 33: 374-413.
-
(1905)
J. Physiol.
, vol.33
, pp. 374-413
-
-
Langley, J.N.1
-
65
-
-
0013679543
-
On some physiological actions of ergot
-
H H Dale, 'On some physiological actions of ergot', J. Physiol., 1906, 34: 163-206.
-
(1906)
J. Physiol.
, vol.34
, pp. 163-206
-
-
Dale, H.H.1
-
66
-
-
30444454989
-
-
London, British Pharmacological Society
-
See W F Bynum, An early history of the British Pharmacological Society, 1931-1981, London, British Pharmacological Society, 1981, pp. 8-9. By the time of the Second World War, Dale's leadership in science administration meant that he was himself no longer closely involved in scientific research.
-
(1981)
An Early History of the British Pharmacological Society, 1931-1981
, pp. 8-9
-
-
Bynum, W.F.1
-
68
-
-
84964166431
-
Pharmacology and nerve-endings
-
on p. 319
-
See also a later article by Dale on 'Pharmacology and nerve-endings', Proc. R. S. Med., 1935, 28: 319-32, on p. 319.
-
(1935)
Proc. R. S. Med.
, vol.28
, pp. 319-332
-
-
Dale1
-
70
-
-
84944488816
-
Chemical structure and sympathomimetic action of amines
-
G Barger and H H Dale, 'Chemical structure and sympathomimetic action of amines', J. Physiol., 1910-1911, 41: 19-59.
-
(1910)
J. Physiol.
, vol.41
, pp. 19-59
-
-
Barger, G.1
Dale, H.H.2
-
71
-
-
84951653316
-
A study of the adrenotropic receptors
-
R P Ahlquist, 'A study of the adrenotropic receptors', Am. J. Phys., 1948, 153: 586-600;
-
(1948)
Am. J. Phys.
, vol.153
, pp. 586-600
-
-
Ahlquist, R.P.1
-
72
-
-
0015857085
-
Adrenergic receptors: A personal and practical view
-
Idem
-
Idem, 'Adrenergic receptors: a personal and practical view', Perspect. Biol. Med., 1973, 17: 119-22.
-
(1973)
Perspect. Biol. Med.
, vol.17
, pp. 119-122
-
-
-
73
-
-
85039254880
-
-
note 28 above
-
Vos, Perspect. Biol. Med., op. cit., note 28 above, pp. 71-2.
-
Perspect. Biol. Med.
, pp. 71-72
-
-
Vos1
-
74
-
-
85039248536
-
Adrenergic receptors
-
note 50 above
-
Ahlquist, 'Adrenergic receptors', Perspect. Biol. Med., op. cit., note 50 above, p. 120.
-
Perspect. Biol. Med.
, pp. 120
-
-
Ahlquist1
-
75
-
-
85039254880
-
-
note 28 above, 76
-
Vos, Perspect. Biol. Med., op. cit., note 28 above, pp. 72, 76.
-
Perspect. Biol. Med.
, pp. 72
-
-
Vos1
-
78
-
-
45049087092
-
Evolution of the dual adrenergic receptor concept: Key to past mysteries and modern therapy
-
Parnham and Bruinvels (eds), note 1 above, on pp. 217-18
-
Also G O Carrier, 'Evolution of the dual adrenergic receptor concept: key to past mysteries and modern therapy', in Parnham and Bruinvels (eds), Perspect. Biol. Med., op. cit., note 1 above, pp. 203-21, on pp. 217-18.
-
Perspect. Biol. Med.
, pp. 203-221
-
-
Carrier, G.O.1
-
81
-
-
84980106102
-
A specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relations to adrenaline and nor-adrenaline
-
U S von Euler, 'A specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relations to adrenaline and nor-adrenaline', Acta. Physiol. Scand., 1946, 12: 73-97;
-
(1946)
Acta. Physiol. Scand.
, vol.12
, pp. 73-97
-
-
Von Euler, U.S.1
-
82
-
-
15444342467
-
The pharmacological activity of epinephrine and related dihydroxyphenylalkylamines
-
on p. 301
-
A M Lands, 'The pharmacological activity of epinephrine and related dihydroxyphenylalkylamines', Pharmacol. Rev., 1949, 1: 279-309, on p. 301.
-
(1949)
Pharmacol. Rev.
, vol.1
, pp. 279-309
-
-
Lands, A.M.1
-
83
-
-
85039243543
-
-
note 5 above
-
Black, Pharmacol. Rev., op. cit., note 5 above, p. 12.
-
Pharmacol. Rev.
, pp. 12
-
-
Black1
-
84
-
-
0037896297
-
-
Clifton, NJ, Humana Press
-
See R A Maxwell and S B Eckhardt, Drug discovery: a casebook and analysis, Clifton, NJ, Humana Press, 1990, p. 13.
-
(1990)
Drug Discovery: A Casebook and Analysis
, pp. 13
-
-
Maxwell, R.A.1
Eckhardt, S.B.2
-
85
-
-
0344926862
-
Design of β-blocking drugs
-
in E J Ariëns (ed.), New York, Academic Press, on p. 208
-
Also A M Barrett, 'Design of β-blocking drugs', in E J Ariëns (ed.), Drug design, New York, Academic Press, 1972, vol. 3, pp. 205-28, on p. 208;
-
(1972)
Drug Design
, vol.3
, pp. 205-228
-
-
Barrett, A.M.1
-
86
-
-
2042485983
-
The discovery of beta adrenoceptor blocking drugs
-
M J Parnham and J Bruinvels (eds), Amsterdam, Elsevier
-
R G Shanks, 'The discovery of beta adrenoceptor blocking drugs', in M J Parnham and J Bruinvels (eds), Discoveries in pharmacology, vol. 2, Haemodynamics, hormones and inflammation, Amsterdam, Elsevier, 1984, pp. 38-72.
-
(1984)
Discoveries in Pharmacology, Vol. 2, Haemodynamics, Hormones and Inflammation
, pp. 38-72
-
-
Shanks, R.G.1
-
87
-
-
0000444291
-
Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol
-
C E Powell and I H Slater, 'Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol', J. Pharm. exp. Ther., 1958, 122: 480-8;
-
(1958)
J. Pharm. Exp. Ther.
, vol.122
, pp. 480-488
-
-
Powell, C.E.1
Slater, I.H.2
-
88
-
-
0343418277
-
Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol
-
N C Moran and M E Perkins, 'Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol', J. Pharm. exp. Ther., 1958, 124: 223-37.
-
(1958)
J. Pharm. Exp. Ther.
, vol.124
, pp. 223-237
-
-
Moran, N.C.1
Perkins, M.E.2
-
90
-
-
0012239443
-
Trails of Discovery 1: The importance of chance and the prepared mind in the discovery of the beta-blockers
-
p. 172
-
J D Fitzgerald, 'Trails of Discovery 1): The importance of chance and the prepared mind in the discovery of the beta-blockers', Dialogues in Cardiovascular Medicine, 2000, 5: 172-6, p. 172.
-
(2000)
Dialogues in Cardiovascular Medicine
, vol.5
, pp. 172-176
-
-
Fitzgerald, J.D.1
-
92
-
-
30444437889
-
Drugs from emasculated hormones: The principles of synoptic antagonism' (Nobel Lecture, Dec. 8 1988)
-
T Frängsmyr (ed.), Singapore, World Scientific, on pp. 418-19;
-
J W Black, 'Drugs from emasculated hormones: the principles of synoptic antagonism' (Nobel Lecture, Dec. 8 1988), in T Frängsmyr (ed.), Nobel lectures in physiology or medicine, 1981-1990, Singapore, World Scientific, 1993, pp. 418-39, on pp. 418-19;
-
(1993)
Nobel Lectures in Physiology or Medicine, 1981-1990
, pp. 418-439
-
-
Black, J.W.1
-
96
-
-
0003982544
-
-
London, Edinburgh, Churchill Livingstone, esp. 'Historical Introduction', on pp. 2-3
-
J M Cruickshank and B N C Prichard, Beta-blockers in clinical practice, 2nd ed., London, Edinburgh, Churchill Livingstone, 1994, esp. 'Historical Introduction', pp. 1-7, on pp. 2-3.
-
(1994)
Beta-blockers in Clinical Practice, 2nd Ed.
, pp. 1-7
-
-
Cruickshank, J.M.1
Prichard, B.N.C.2
-
97
-
-
85039244852
-
Biography of James W Black
-
Frängsmyr (ed.), note 65 above
-
See Black's reminiscences on the occasion of his Nobel Prize, in J W Black, 'Biography of James W Black', in Frängsmyr (ed.), Beta-blockers in Clinical Practice, 2nd Ed., op. cit., note 65 above, pp. 413-17.
-
Beta-blockers in Clinical Practice, 2nd Ed.
, pp. 413-417
-
-
Black, J.W.1
-
99
-
-
0031299860
-
Sir James Black and propranolol
-
on pp. 338-9
-
also M P Stapleton, 'Sir James Black and propranolol', Tex. Heart Inst. J., 1997, 24: 336-42, on pp. 338-9.
-
(1997)
Tex. Heart Inst. J.
, vol.24
, pp. 336-342
-
-
Stapleton, M.P.1
-
100
-
-
85039248628
-
-
note 28 above
-
Vos, Tex. Heart Inst. J., op. cit., note 28 above, p. 83.
-
Tex. Heart Inst. J.
, pp. 83
-
-
Vos1
-
101
-
-
85039254903
-
Biography
-
Frängsmyr (ed.), note 69 above
-
Black, 'Biography', in Frängsmyr (ed.), Tex. Heart Inst. J., op. cit., note 69 above, pp. 414-15.
-
Tex. Heart Inst. J.
, pp. 414-415
-
-
Black1
-
102
-
-
85039247516
-
James Black, English pharmacologist
-
E J McMurray (ed.), 4 vols, New York, Gale Research, on p. 185
-
K H George, 'James Black, English pharmacologist', in E J McMurray (ed.), Notable twentieth-century scientists, 4 vols, New York, Gale Research, 1995, vol. 1, pp. 185-7, on p. 185. George was obviously unaware that Black is Scottish, not English.
-
(1995)
Notable Twentieth-century Scientists
, vol.1
, pp. 185-187
-
-
George, K.H.1
-
103
-
-
85039247575
-
Drugs from emasculated hormones
-
Frängsmyr (ed.), note 65 above
-
See also Black, 'Drugs from emasculated hormones', in Frängsmyr (ed.), Notable Twentieth-century Scientists, op. cit., note 65 above, p. 425.
-
Notable Twentieth-century Scientists
, pp. 425
-
-
Black1
-
109
-
-
85039250692
-
-
in a personal communication to Maxwell and Eckhardt, note 60 above
-
Shanks, in a personal communication to Maxwell and Eckhardt, Notable Twentieth-century Scientists, op. cit., note 60 above, p. 13.
-
Notable Twentieth-century Scientists
, pp. 13
-
-
Shanks1
-
115
-
-
33845288879
-
Electrocardiographic changes produced in rabbits by vasopressin (pitressin) and their alteration by prolonged treatment with a commercial heart extract
-
Black published his results in 1959. J W Black, 'Electrocardiographic changes produced in rabbits by vasopressin (pitressin) and their alteration by prolonged treatment with a commercial heart extract', J. Pharm. Pharmacol, 1960, 12: 87-94;
-
(1960)
J. Pharm. Pharmacol
, vol.12
, pp. 87-94
-
-
Black, J.W.1
-
116
-
-
85039246152
-
-
22 Jan.
-
he also mentioned this research in his first report for ICI. ICI CPR 50: Research Department Report 50/3, 22 Jan. 1959.
-
(1959)
ICI CPR 50: Research Department Report
, vol.50
, Issue.3
-
-
-
117
-
-
85039245457
-
Biography
-
Frängsmyr (ed.), note 69 above, and personal communication
-
Black, 'Biography', Frängsmyr (ed.), ICI CPR 50: Research Department Report, op. cit., note 69 above, p. 415, and personal communication.
-
ICI CPR 50: Research Department Report
, pp. 415
-
-
Black1
-
118
-
-
33845319149
-
-
8 Jul.
-
ICI CPR 1: 8 Jul. 1951;
-
(1951)
ICI CPR
, vol.1
-
-
-
119
-
-
85039245270
-
-
31 March
-
ICI CPR 3: 31 March 1948.
-
(1948)
ICI CPR
, vol.3
-
-
-
120
-
-
85039242024
-
-
note 12 above
-
See Holland, ICI CPR, op. cit., note 12 above, p. 286;
-
ICI CPR
, pp. 286
-
-
Holland, S.1
-
121
-
-
85039253509
-
-
visit of Veterinary Services Department to Glasgow Veterinary College and Hospital, 12 Nov.
-
also ICI CPR 2: Development Memo for Oct. 1957: visit of Veterinary Services Department to Glasgow Veterinary College and Hospital, 12 Nov. 1957.
-
(1957)
ICI CPR 2: Development Memo for Oct. 1957
-
-
-
124
-
-
85039244976
-
-
note
-
The importance of Horsfall's contribution was later recognized by having a new section, called the Biological Electronics Unit, created for him in the Biology/Biochemistry Department. ICI DO772: Administration Section organization chart, 18 March 1971.
-
-
-
-
125
-
-
85039252674
-
-
Woodbridge, op. cit., note 18 above, p. 154 (based on an interview with Black)
-
Woodbridge, op. cit., note 18 above, p. 154 (based on an interview with Black).
-
-
-
-
126
-
-
85039249046
-
-
Woodbridge, op. cit., ibid., p. 143
-
In 1933, Fourneau synthesized piperoxane, the first of a new class of adrenergic blockers (Woodbridge, op. cit., ibid., p. 143).
-
-
-
-
127
-
-
33845317536
-
Recherches sur l'action sympatholytique de nouveaux dérivés du dioxane
-
Although the article in Comptes Rendus was not cited by Woodbridge, it is likely that it was E Fourneau and D Bovet, 'Recherches sur l'action sympatholytique de nouveaux dérivés du dioxane', C. r. Soc. biol. fil., 1933, 113: 388-90.
-
(1933)
C. R. Soc. Biol. Fil.
, vol.113
, pp. 388-390
-
-
Fourneau, E.1
Bovet, D.2
-
129
-
-
85039246308
-
-
The Swedish company A B Hassle, which merged first into Astra, and then with ICI's Pharmaceutical Division to form AstraZeneca, also picked up in 1963 the trail left by Fourneau, but unlike ICI did not abandon it (Vos, C. R. Soc. Biol. Fil., op. cit., ibid., p. 110).
-
C. R. Soc. Biol. Fil.
, pp. 110
-
-
Vos1
-
130
-
-
85039252510
-
-
note 63 above
-
More intriguingly still, in 1915 Fourneau had described the synthesis of phenoxypropanolamines, one of which was later synthesized by ICI and shown to be a beta-blocker. However, back in 1915, the effects of these compounds on the heart was thought to preclude them from being useful in the clinic. See Fitzgerald, C. R. Soc. Biol. Fil., op. cit., note 63 above, p. 174.
-
C. R. Soc. Biol. Fil.
, pp. 174
-
-
Fitzgerald1
-
131
-
-
85039251114
-
Drugs from emasculated hormones
-
note 65 above
-
Black, 'Drugs from emasculated hormones', C. R. Soc. Biol. Fil., op. cit., note 65 above, p. 420.
-
C. R. Soc. Biol. Fil.
, pp. 420
-
-
Black1
-
133
-
-
0029992470
-
A personal view of pharmacology
-
on pp. 2-3
-
See also J W Black, 'A personal view of pharmacology', Annu. Rev. Pharmacol. Toxicol, 1996, 36: 1-33, on pp. 2-3.
-
(1996)
Annu. Rev. Pharmacol. Toxicol
, vol.36
, pp. 1-33
-
-
Black, J.W.1
-
135
-
-
85039250720
-
-
22 Jan.
-
ICI CPR 50: 50/3, 22 Jan. 1959.
-
(1959)
ICI CPR 50
, vol.50
, Issue.3
-
-
-
136
-
-
33845343856
-
-
ICI CPR 50: 1959. Ibid.
-
(1959)
ICI CPR 50
-
-
-
137
-
-
85039254436
-
-
note 60 above
-
Barrett, ICI CPR 50, op. cit., note 60 above, p. 213.
-
ICI CPR 50
, pp. 213
-
-
Barrett1
-
138
-
-
85039252851
-
-
14 June
-
ICI CPR 50/6: 14 June 1960.
-
(1960)
ICI CPR
, vol.50
, Issue.6
-
-
-
139
-
-
85039246561
-
-
note 28 above
-
Vos, ICI CPR, op. cit., note 28 above, p. 85.
-
ICI CPR
, pp. 85
-
-
Vos1
-
140
-
-
85039248155
-
-
note 18 above
-
Woodbridge, ICI CPR, op. cit., note 18 above, p. 176.
-
ICI CPR
, pp. 176
-
-
Woodbridge1
-
141
-
-
85039248155
-
-
177
-
Woodbridge, ICI CPR, op. cit., Ibid., pp. 158, 177.
-
ICI CPR
, pp. 158
-
-
Woodbridge1
-
142
-
-
85039247217
-
-
22 Aug.
-
Although he had been at ICI for longer, Dunlop's name first appeared in connection with the cardiovascular programme in 1958. See ICI CPR 53/2: 22 Aug. 1958.
-
(1958)
ICI CPR
, vol.53
, Issue.2
-
-
-
143
-
-
85039242806
-
-
Nov.-Dec. to Jan.
-
Barrett's name is first mentioned in ICI CPR 99 IB: Nov.-Dec. 1964 to Jan. 1965.
-
(1964)
ICI CPR
, vol.99
, Issue.IB
-
-
-
144
-
-
85039247284
-
-
note 60 above
-
Barrett, ICI CPR, op. cit., note 60 above, p. 214.
-
ICI CPR
, pp. 214
-
-
Barrett1
-
145
-
-
85039242673
-
-
21 Aug.
-
ICI CPR 50/8: 21 Aug. 1961;
-
(1961)
ICI CPR
, vol.50
, Issue.8
-
-
-
146
-
-
85039249015
-
-
26 Jan.
-
ICI CPR 56/8: 26 Jan. 1962.
-
(1962)
ICI CPR
, vol.56
, Issue.8
-
-
-
147
-
-
85039249706
-
-
26 Jan.
-
ICI CPR 56/8: 26 Jan. 1962.
-
(1962)
ICI CPR
, vol.56
, Issue.8
-
-
-
148
-
-
33845338692
-
-
7 Nov.
-
ICI CPR 50/9: 7 Nov. 1962.
-
(1962)
ICI CPR
, vol.50
, Issue.9
-
-
-
149
-
-
33845348546
-
-
7 Nov.
-
ICI CPR 56/9: 7 Nov. 1962.
-
(1962)
ICI CPR
, vol.56
, Issue.9
-
-
-
150
-
-
33845328736
-
-
7 Nov.
-
ICI CPR 56/9: 7 Nov. 1962.
-
(1962)
ICI CPR
, vol.56
, Issue.9
-
-
-
151
-
-
85039254747
-
-
note 4 above
-
The synthetic anti-histamines used at the time, such as mepyramine and diphenhydramine, did not inhibit the acid secretion stimulated by histamine, hence Black came up with the idea of finding a selective antagonist of histamine's "beta-receptors". See Gerskowitch, et al., ICI CPR, op. cit., note 4 above, p. 436.
-
ICI CPR
, pp. 436
-
-
Gerskowitch1
-
152
-
-
33845311104
-
War and change in the pharmaceutical industry: A comparative study of Britain and France in the twentieth century
-
NB: the first synthetic anti-histamines had in fact been developed by Daniel Bovet, working in Fourneau's laboratory in collaboration with Rhône-Poulenc. See V Quirke, 'War and change in the pharmaceutical industry: a comparative study of Britain and France in the twentieth century', special issue of Enterprise and History, 2004, 36: 64-83.
-
(2004)
Special Issue of Enterprise and History
, vol.36
, pp. 64-83
-
-
Quirke, V.1
-
155
-
-
85039252281
-
-
Vos's note 62, on p. 293
-
see also Vos's note 62, on p. 293.
-
-
-
-
156
-
-
85039242051
-
-
Woodbridge, op. cit., note 18 above, pp. 182-3
-
Woodbridge, op. cit., note 18 above, pp. 182-3.
-
-
-
-
157
-
-
85039254928
-
-
Woodbridge, op. cit., Ibid., p. 189
-
Woodbridge, op. cit., Ibid., p. 189.
-
-
-
-
158
-
-
85039254498
-
-
Welwyn Garden City, Smith Kline & French Laboratories Ltd.
-
L Finucane, SK&F: from Camberwell to Welwyn Garden City, 1956-1989, Welwyn Garden City, Smith Kline & French Laboratories Ltd., 1989, p. 49.
-
(1989)
SK&F: from Camberwell to Welwyn Garden City, 1956-1989
, pp. 49
-
-
Finucane, L.1
-
159
-
-
85039246959
-
-
16 June
-
Paget's name first appears in connection with ICI's cardiovascular programme in 1959. See ICI CPR 50/4: 16 June 1959.
-
(1959)
ICI CPR
, vol.50
, Issue.4
-
-
-
160
-
-
85039251518
-
-
24 Apr.
-
ICI CPR 56, 56/12: 24 Apr. 1964.
-
(1964)
ICI CPR 56
, vol.56
, Issue.12
-
-
-
161
-
-
85039248155
-
-
note 18 above
-
Woodbridge, ICI CPR, op. cit., note 18 above, pp. 191-3.
-
ICI CPR
, pp. 191-193
-
-
Woodbridge1
-
162
-
-
85039246561
-
-
note 28 above
-
On Black's enduring influence, see Vos, ICI CPR, op. cit., note 28 above, p. 89.
-
ICI CPR
, pp. 89
-
-
Vos1
-
163
-
-
85039248155
-
-
note 18 above
-
Woodbridge, ICI CPR, op. cit., note 18 above, p. 193.
-
ICI CPR
, pp. 193
-
-
Woodbridge1
-
164
-
-
33845300764
-
-
Feb.-Apr.
-
ICI CPR 99, 2B: Feb.-Apr. 1965;
-
(1965)
ICI CPR
, vol.99
, Issue.2 B
-
-
-
165
-
-
33845337555
-
-
May-Aug.
-
CPR 99 3B: May-Aug. 1965.
-
(1965)
CPR
, vol.99
, Issue.3 B
-
-
-
166
-
-
85039242306
-
-
24 Apr.
-
ICI CPR 56/12: 24 Apr. 1964;
-
(1964)
ICI CPR
, vol.56
, Issue.12
-
-
-
167
-
-
85039246531
-
-
13 Nov.
-
CPR 56/13: 13 Nov. 1964.
-
(1964)
CPR
, vol.56
, Issue.13
-
-
-
168
-
-
85039246252
-
-
13 Nov.
-
ICI CPR 56/13: 13 Nov. 1964.
-
(1964)
ICI CPR
, vol.56
, Issue.13
-
-
-
169
-
-
85039246773
-
-
note 6 above
-
Kennedy, ICI CPR, op. cit., note 6 above, p. 138;
-
ICI CPR
, pp. 138
-
-
Kennedy1
-
170
-
-
85039246561
-
-
note 28 above
-
Vos, ICI CPR, op. cit., note 28 above, p. 91.
-
ICI CPR
, pp. 91
-
-
Vos1
-
171
-
-
0000776860
-
Use of propranolol in the treatment of hypertension
-
B N C Prichard and P M S Gillam, 'Use of propranolol in the treatment of hypertension', Br. med. J., 1964, ii: 725;
-
(1964)
Br. Med. J.
, vol.2
, pp. 725
-
-
Prichard, B.N.C.1
Gillam, P.M.S.2
-
172
-
-
85039251308
-
-
note 18 above
-
Woodbridge, Br. Med. J., op. cit., note 18 above, p. 197.
-
Br. Med. J.
, pp. 197
-
-
Woodbridge1
-
173
-
-
0017162953
-
The use of propranolol in hypertension: A review
-
Hoffbrand, et al., note 5 above
-
See also L Hansson, 'The use of propranolol in hypertension: a review', in Hoffbrand, et al., Br. Med. J., op. cit., note 5 above, pp. 77-80.
-
Br. Med. J.
, pp. 77-80
-
-
Hansson, L.1
-
174
-
-
85039254660
-
-
note 18 above
-
Woodbridge, Br. Med. J., op. cit., note 18 above, pp. 212-13.
-
Br. Med. J.
, pp. 212-213
-
-
Woodbridge1
-
176
-
-
85039252788
-
-
note 60 above, 226
-
According to Barrett, this is actually an impediment to therapeutic progress. Barrett, Br. Med. J., op. cit., note 60 above, pp. 217, 226.
-
Br. Med. J.
, pp. 217
-
-
Barrett1
-
178
-
-
85039242861
-
-
note 18 above, 214
-
Not only was there Mead Johnson's sotalol, A B Hässle's alprenolol, but also Ciba's oxprenolol, which were all launched around the same time. Woodbridge, Br. Med. J., op. cit., note 18 above, pp. 198-203, 214.
-
Br. Med. J.
, pp. 198-203
-
-
Woodbridge1
-
179
-
-
85039251560
-
-
25 May
-
ICI CPR 99, 5B: 25 May 1966.
-
(1966)
ICI CPR
, vol.99
, Issue.5 B
-
-
-
180
-
-
33845327021
-
-
6 Nov.
-
ICI CPR 99, 9B: 6 Nov. 1967.
-
(1967)
ICI CPR
, vol.99
, Issue.9 B
-
-
-
181
-
-
33845340405
-
Computer technology in drug design
-
E J Ariëns (ed.). New York, Academic Press
-
On the role of computers and information science in drug design, see P J Lewi, 'Computer technology in drug design', in E J Ariëns (ed.). Drug Design, New York, Academic Press, 1976, vol. 7, pp. 209-75.
-
(1976)
Drug Design
, vol.7
, pp. 209-275
-
-
Lewi, P.J.1
-
182
-
-
85039243061
-
-
27 March
-
ICI CPR 99, 13B: 27 March 1969.
-
(1969)
ICI CPR
, vol.99
, Issue.13 B
-
-
-
183
-
-
85039248155
-
-
note 18 above
-
Woodbridge, ICI CPR, op. cit., note 18 above, pp. 219-20.
-
ICI CPR
, pp. 219-220
-
-
Woodbridge1
-
184
-
-
33845334114
-
-
6 Nov.
-
Fitzgerald joined ICI in 1967. See ICI CPR 99, 9B: 6 Nov. 1967.
-
(1967)
ICI CPR
, vol.99
, Issue.9 B
-
-
-
185
-
-
33845284775
-
-
Woodbridge, ICI CPR, op. cit., note 18 above, pp. 232-5.
-
(1918)
ICI CPR
, pp. 232-235
-
-
Woodbridge1
-
186
-
-
33845305725
-
-
8 July
-
ICI CPR 99, 14B: 8 July 1969.
-
(1969)
ICI CPR
, vol.99
, Issue.14 B
-
-
-
187
-
-
85039252210
-
-
27 March
-
ICI CPR 99, 13B: 27 March 1969.
-
(1969)
ICI CPR
, vol.99
, Issue.13 B
-
-
-
188
-
-
85039242714
-
-
note 68 above
-
Membrane-stabilizing activity was later shown to be unimportant in beta-blockade. See Cruickshank and Prichard, ICI CPR, op. cit., note 68 above, p. 7.
-
ICI CPR
, pp. 7
-
-
Cruickshank1
Prichard2
-
189
-
-
85039248155
-
-
note 18 above
-
Woodbridge, ICI CPR, op. cit., note 18 above, pp. 254-5.
-
ICI CPR
, pp. 254-255
-
-
Woodbridge1
-
191
-
-
33845317185
-
-
8 July
-
ICI CPR 99, 14B: 8 July 1969.
-
(1969)
ICI CPR
, vol.99
, Issue.14 B
-
-
-
192
-
-
33845330505
-
-
8 July
-
ICI CPR 99, 14B: 8 July 1969.
-
(1969)
ICI CPR
, vol.99
, Issue.14 B
-
-
-
193
-
-
0013266943
-
-
London, Profile Books
-
On the history of Ventolin, see E Jones, The business of medicine, London, Profile Books, 2001, pp. 330-3.
-
(2001)
The Business of Medicine
, pp. 330-333
-
-
Jones, E.1
-
194
-
-
84940024769
-
-
Oxford University Press
-
A technique by which fixed ligands bind the receptors in a solution, preventing their flow through a chromatography column, with the effect of separating them from other materials. See J D Robinson, Mechanisms of synaptic transmission: bridging the gaps (1890-1990), Oxford University Press, 2001, p. 159.
-
(2001)
Mechanisms of Synaptic Transmission: Bridging the Gaps (1890-1990)
, pp. 159
-
-
Robinson, J.D.1
-
196
-
-
85039250886
-
-
27 Feb.
-
ICI CPR 99, 25B: 27 Feb. 1973.
-
(1973)
ICI CPR
, vol.99
, Issue.25 B
-
-
-
197
-
-
0003877811
-
-
New York, Marcel Dekker
-
On the importance of quantitative-activity studies in the rise of a rational approach to drug design, see for instance Y C Martin, Quantitative drug design: a critical introduction, New York, Marcel Dekker, 1978.
-
(1978)
Quantitative Drug Design: A Critical Introduction
-
-
Martin, Y.C.1
-
198
-
-
85039252627
-
-
16 June
-
ICI CPR 99, 23B: 16 June 1972.
-
(1972)
ICI CPR
, vol.99
, Issue.23 B
-
-
-
199
-
-
33845284774
-
-
7 March
-
ICI CPR 99, 22B: 7 March 1972.
-
(1972)
ICI CPR
, vol.99
, Issue.22 B
-
-
-
200
-
-
85039251311
-
-
note 143 above
-
On Hansch's method see Martin, ICI CPR, op. cit, note 143 above,
-
ICI CPR
-
-
Martin1
-
201
-
-
84860241790
-
The use of linear free energy parameters and other experimental constants in structure-activity studies
-
Ariens (ed.), note 60 above
-
and also A Verloop, 'The use of linear free energy parameters and other experimental constants in structure-activity studies', in Ariens (ed.), ICI CPR, op. cit., note 60 above, pp. 133-88.
-
ICI CPR
, pp. 133-188
-
-
Verloop, A.1
-
202
-
-
85039248392
-
-
16 June
-
ICI CPR 99, 23B: 16 June 1972.
-
(1972)
ICI CPR
, vol.99
, Issue.23 B
-
-
-
203
-
-
85039253023
-
-
note 63 above
-
Unlike Black, Hässle's researchers believed that moderate beta-receptor stimulant action was useful in a beta-blocker, therefore it is likely that this change of position on ICI's part was a response to competitors' drugs coming onto the market. See Fitzgerald, ICI CPR, op. cit., note 63 above, p. 174.
-
ICI CPR
, pp. 174
-
-
Fitzgerald1
-
204
-
-
85039249380
-
-
16 June
-
ICI CPR 99, 23B: 16 June 1972.
-
(1972)
ICI CPR
, vol.99
, Issue.23 B
-
-
-
205
-
-
85039251851
-
-
23 Oct.
-
ICI CPR B 99, 30B: 23 Oct. 1974.
-
(1974)
ICI CPR B
, vol.99
, Issue.30 B
-
-
-
206
-
-
85039249601
-
-
23 Oct.
-
ICI CPR B 99, 30B: 23 Oct. 1974.
-
(1974)
ICI CPR B
, vol.99
, Issue.30 B
-
-
-
207
-
-
25044473190
-
Receptors: From fiction to fact
-
On this progress from hypothetical entity to tangible object see E J Ariëns, 'Receptors: from fiction to fact', Trends Pharmacol. Sci. inaugural issue, 1979, pp. 11-15;
-
(1979)
Trends Pharmacol. Sci. Inaugural Issue
, pp. 11-15
-
-
Ariëns, E.J.1
-
209
-
-
85039246815
-
-
20 Oct.
-
ICI CPR B 99, 33B: 20 Oct. 1975.
-
(1975)
ICI CPR B
, vol.99
, Issue.33 B
-
-
-
210
-
-
0014194186
-
Differentiation of receptor systems activated by sympathomimetic amines
-
2 receptors in 1967, concluding that while the former was prominent in cardiac stimulation, the latter played an important role in bronchodilation. A M Lands, et al., 'Differentiation of receptor systems activated by sympathomimetic amines', 1967, Nature, 214: 597-8.
-
(1967)
Nature
, vol.214
, pp. 597-598
-
-
Lands, A.M.1
-
211
-
-
85039252565
-
-
note 140 above
-
See Robinson, Nature, op. cit., note 140 above, p. 154.
-
Nature
, pp. 154
-
-
Robinson1
-
212
-
-
85039243600
-
-
22 Oct.
-
2 receptors were mentioned in ICI's research reports was in CPR 99, 27B: 22 Oct. 1973.
-
(1973)
CPR
, vol.99
, Issue.27 B
-
-
-
213
-
-
85039246229
-
-
23 Oct.
-
ICI CPR B 99, 30B: 23 Oct. 1974.
-
(1974)
ICI CPR B
, vol.99
, Issue.30 B
-
-
-
214
-
-
85039248664
-
-
26 Feb.
-
ICI CPR B 99, 34B: 26 Feb. 1976.
-
(1976)
ICI CPR B
, vol.99
, Issue.34 B
-
-
-
215
-
-
85039252890
-
-
Nov.-Dec. to Jan.
-
ICI CPR 99, 1B: Nov.-Dec. 1964 to Jan. 1965.
-
(1964)
ICI CPR
, vol.99
, Issue.1 B
-
-
-
216
-
-
33845312209
-
-
July
-
ICI CPR B 99, 35B: July 1976.
-
(1976)
ICI CPR B
, vol.99
, Issue.35 B
-
-
-
217
-
-
85039252249
-
-
note 112 above, ch. 10.
-
l57 See Finucane, ICI CPR B, op. cit., note 112 above, ch. 10.
-
ICI CPR B
-
-
Finucane1
-
218
-
-
85039251698
-
-
note 60 above
-
On the history of cimetidine, see also Maxwell and Eckhardt, ICI CPR B, op. cit., note 60 above, pp. 365-76;
-
ICI CPR B
, pp. 365-376
-
-
Maxwell1
Eckhardt2
-
219
-
-
4243303017
-
Histamine receptor antagonists
-
Parnham and Bruinvels (eds), note 60 above
-
and M Ennis and W Lorenz, 'Histamine receptor antagonists', in Parnham and Bruinvels (eds), ICI CPR B, op. cit., note 60 above, pp. 623-45.
-
ICI CPR B
, pp. 623-645
-
-
Ennis, M.1
Lorenz, W.2
-
220
-
-
85039242318
-
-
note 12 above
-
Holland, ICI CPR B, op. cit., note 12 above, p. 288.
-
ICI CPR B
, pp. 288
-
-
Holland1
-
221
-
-
85039242318
-
-
Holland, ICI CPR B, op. cit., Ibid., pp. 286-7.
-
ICI CPR B
, pp. 286-287
-
-
Holland1
-
222
-
-
85039252249
-
-
note 112 above
-
On the parallels between the two projects, see Finucane, ICI CPR B, op. cit., note 112 above, p. 50.
-
ICI CPR B
, pp. 50
-
-
Finucane1
-
223
-
-
85039245457
-
Biography
-
note 69 above
-
Black, 'Biography', ICI CPR B, op. cit., note 69 above, p. 415.
-
ICI CPR B
, pp. 415
-
-
Black1
-
224
-
-
85039246058
-
-
note 24 above
-
Davey, ICI CPR B, op. cit., note 24 above.
-
ICI CPR B
-
-
Davey1
-
225
-
-
0011270859
-
Invention in the industrial research laboratory: Individual act or collective process?
-
R J Weber and D N Perkins, New York, Oxford University Press
-
D A Hounshell, 'Invention in the industrial research laboratory: individual act or collective process?', in R J Weber and D N Perkins, Inventive minds: creativity in technology, New York, Oxford University Press, 1992, pp. 273-90.
-
(1992)
Inventive Minds: Creativity in Technology
, pp. 273-290
-
-
Hounshell, D.A.1
-
226
-
-
1942466274
-
Men, molecules and machines
-
inaugural issue
-
See A W Cuthbert, 'Men, molecules and machines', Trends Pharmacol. Sci. inaugural issue (1979): 1-3, on p. 3.
-
(1979)
Trends Pharmacol. Sci.
, vol.1-3
, pp. 3
-
-
Cuthbert, A.W.1
|